Seeing Is Believing
CRBP is currently covered by 2 analysts with an average price target of $344.2. This is a potential upside of $308.66 (868.49%) from yesterday's end of day stock price of $35.54.
Corbus Pharmaceuticals's activity chart (see below) currently has 9 price targets and 15 ratings on display. The stock rating distribution of CRBP is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 26.39% with an average time for these price targets to be met of 31.67 days.
Highest price target for CRBP is $22, Lowest price target is $22, average price target is $344.2.
Most recent stock forecast was given by JAMES EDWARDES JONES from RBC on 09-Aug-2023. First documented stock forecast 25-Oct-2016.
Currently out of the existing stock ratings of CRBP, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
22
$-13 (-37.14%)
22
8 months 16 days ago
2/2 (100%)
$15.85 (257.72%)
216
Buy
3
$-32.54 (-91.56%)
3
1 years 1 months 17 days ago
2/2 (100%)
$0.48 (19.05%)
7
Hold
53.7
$18.16 (51.10%)
36.6
3 years 1 months 10 days ago
3/8 (37.5%)
$-14.4 (-21.15%)
62
Buy
690
3 years 7 months 17 days ago
0/1 (0%)
$483 (233.33%)
Hold
660
3 years 7 months 17 days ago
0/1 (0%)
$425.4 (181.33%)
What is CRBP (Corbus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CRBP (Corbus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CRBP (Corbus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CRBP (Corbus Pharmaceuticals)?
Which analyst is the currently most bullish on CRBP (Corbus Pharmaceuticals)?
Which analyst is the currently most reserved on CRBP (Corbus Pharmaceuticals)?